The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CL | COLGATE PALMOLIVE CO | 2026-03-03 04:35:16 | 96.97 | -0.31 | -0.31 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CL | 0000021665 | COLGATE PALMOLIVE CO | US1941621039 | YMEGZFW4SBUSS5BQXF88 | 131815595 | NYSE | 2844 | Perfumes, Cosmetics & Other Toilet Preparations | 1231 | DE | 300 PARK AVE | NEW YORK | NY | 10022 | UNITED STATES | US | 2123102000 | 300 PARK AVE, NEW YORK, NY, 10022 | 300 PARK AVE, NEW YORK, NY, 10022 | COLGATE PALMOLIVE CO | Consumer goods | 1806 | Noel Wallace | 34,000 | https://colgatepalmolive.com | 73,400,000,000 | 1,465,706,360 | 801,548,028 | The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products. | 2026-02-26 15:19:26 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 73,400,000,000 | -5,800,000,000 | -7.3232 | 801,548,028 | -9,988,409 | -1.2308 |
| 2024 | 79,200,000,000 | 15,600,000,000 | 24.5283 | 811,536,437 | -11,614,482 | -1.411 |
| 2023 | 63,600,000,000 | -3,200,000,000 | -4.7904 | 823,150,919 | -7,227,871 | -0.8704 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jennifer M. Daniels | Chief Legal Officer, Secretary | 2024 | 921,815 | 0 | 1,384,831 | 1,297,131 | 170,426 | 4,353,205 |
| Prabha Parameswaran | Group President | 2024 | 947,215 | 0 | 1,481,388 | 1,332,872 | 230,746 | 4,732,926 |
| Noel Wallace | Chief Executive Officer, Chairman, President | 2024 | 1,500,000 | 0 | 7,893,014 | 4,567,500 | 918,154 | 18,234,864 |
| Stanley J. Sutula | Chief Financial Officer | 2024 | 1,007,513 | 0 | 2,080,962 | 1,772,152 | 203,942 | 5,934,578 |
| Panagiotis Tsourapas | Group President | 2024 | 947,215 | 0 | 1,384,831 | 1,332,872 | 231,069 | 4,479,691 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 33,600 |
| 2024 | 34,000 |
| 2023 | 34,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 20,382,000,000 | 20,101,000,000 | 19,457,000,000 |
| Cost Of Revenue | 8,131,000,000 | 7,940,000,000 | 8,131,000,000 |
| Gross Profit | 12,251,000,000 | 12,161,000,000 | 11,326,000,000 |
| Research And Development Expenses | 366,000,000 | 355,000,000 | 343,000,000 |
| General And Administrative Expenses | 7,903,000,000 | 7,729,000,000 | 7,151,000,000 |
| Operating Expenses | — | — | — |
| Operating Income | 3,306,000,000 | 4,268,000,000 | 3,984,000,000 |
| Net Income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 |
| Earnings Per Share Basic | 2.64 | 3.53 | 2.78 |
| Earnings Per Share Diluted | 2.63 | 3.51 | 2.77 |
| Weighted Average Shares Outstanding Basic | 808,700,000 | 819,100,000 | 827,400,000 |
| Weighted Average Shares Outstanding Diluted | 811,100,000 | 823,200,000 | 829,200,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,288,000,000 | 1,096,000,000 | 966,000,000 |
| Marketable Securities Current | 107,000,000 | 160,000,000 | — |
| Accounts Receivable | 1,675,000,000 | 1,521,000,000 | 1,586,000,000 |
| Inventories | 2,032,000,000 | 1,987,000,000 | 1,934,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 714,000,000 | 713,000,000 | 793,000,000 |
| Total Assets Current | 5,709,000,000 | 5,317,000,000 | 5,279,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 4,660,000,000 | 4,422,000,000 | 4,582,000,000 |
| Other Assets Non Current | 1,098,000,000 | 1,084,000,000 | 1,021,000,000 |
| Total Assets Non Current | 10,621,000,000 | 10,729,000,000 | 11,114,000,000 |
| Total Assets | 16,330,000,000 | 16,046,000,000 | 16,393,000,000 |
| Accounts Payable | 2,089,000,000 | 1,805,000,000 | 1,698,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 1,115,000,000 | 652,000,000 | 20,000,000 |
| Other Liabilities Current | 383,000,000 | 403,000,000 | 336,000,000 |
| Total Liabilities Current | 6,853,000,000 | 5,759,000,000 | 4,741,000,000 |
| Long Term Debt | 7,839,000,000 | 7,005,000,000 | 8,219,000,000 |
| Other Liabilities Non Current | 2,060,000,000 | 2,111,000,000 | 2,115,000,000 |
| Total Liabilities Non Current | 9,112,000,000 | 9,743,000,000 | 10,695,000,000 |
| Total Liabilities | 15,965,000,000 | 15,502,000,000 | 15,436,000,000 |
| Common Stock | 1,466,000,000 | 1,466,000,000 | 1,466,000,000 |
| Retained Earnings | 26,595,000,000 | 26,145,000,000 | 25,289,000,000 |
| Accumulated Other Comprehensive Income | -3,879,000,000 | -4,222,000,000 | -3,937,000,000 |
| Total Shareholders Equity | 54,000,000 | 212,000,000 | 609,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 630,000,000 | 605,000,000 | 567,000,000 |
| Share Based Compensation Expense | 155,000,000 | 135,000,000 | 122,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 16,000,000 | 56,000,000 | 37,000,000 |
| Change In Inventories | -109,000,000 | 100,000,000 | -194,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | — | 516,000,000 | 309,000,000 |
| Change In Other Liabilities | — | 16,000,000 | 11,000,000 |
| Cash From Operating Activities | 4,198,000,000 | 4,107,000,000 | 3,745,000,000 |
| Purchases Of Marketable Securities | 698,000,000 | 574,000,000 | 506,000,000 |
| Sales Of Marketable Securities | 752,000,000 | 564,000,000 | 502,000,000 |
| Acquisition Of Property Plant And Equipment | 564,000,000 | 561,000,000 | 705,000,000 |
| Acquisition Of Business | 293,000,000 | 0 | 0 |
| Other Investing Activities | 14,000,000 | -37,000,000 | 33,000,000 |
| Cash From Investing Activities | -817,000,000 | -534,000,000 | -742,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 1,823,000,000 | 1,789,000,000 | 1,749,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 1,210,000,000 | 1,739,000,000 | 1,128,000,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 132,000,000 | -91,000,000 | 18,000,000 |
| Cash From Financing Activities | -3,256,000,000 | -3,389,000,000 | -2,793,000,000 |
| Change In Cash | 192,000,000 | 130,000,000 | 191,000,000 |
| Cash At End Of Period | 1,288,000,000 | 1,096,000,000 | 966,000,000 |
| Income Taxes Paid | 913,000,000 | 933,000,000 | 937,000,000 |
| Interest Paid | 270,000,000 | 302,000,000 | 280,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 2.64 | 3.53 | 2.78 |
| Price To Earnings Ratio | 29.9318 | 25.7535 | 28.6727 |
| Earnings Growth Rate | -25.2125 | 26.9784 | 30.5164 |
| Price Earnings To Growth Ratio | -1.1872 | 0.9546 | 0.9396 |
| Book Value Per Share | 0.4513 | 0.6641 | 1.1566 |
| Price To Book Ratio | 175.078 | 136.8831 | 68.9154 |
| Ebitda | 3,942,000,000 | 4,719,000,000 | 4,103,000,000 |
| Enterprise Value | 71,569,474,000 | 81,025,381,000 | 73,225,054,000 |
| Dividend Yield | 0.0285 | 0.024 | 0.0265 |
| Dividend Payout Ratio | 0.8551 | 0.6192 | 0.7604 |
| Debt To Equity Ratio | 165.8148 | 36.1179 | 13.5287 |
| Capital Expenditures | 868,000,000 | 445,000,000 | 842,000,000 |
| Free Cash Flow | 3,330,000,000 | 3,662,000,000 | 2,903,000,000 |
| Return On Equity | 39.4815 | 13.6274 | 3.7767 |
| One Year Beta | 0.0333 | 0.0465 | 0.2884 |
| Three Year Beta | 0.0975 | 0.3114 | 0.351 |
| Five Year Beta | 0.2362 | 0.4996 | 0.5335 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Hazlin John | Chief Growth Officer | 2026-02-23 | 12,803 | A | 30,539 |
| Hazlin John | Chief Growth Officer | 2026-02-23 | 6,117 | D | 24,422 |
| Wallace Noel R. | Director, Chairman, President & CEO | 2026-02-23 | 136,710 | A | 430,173 |
| Wallace Noel R. | Director, Chairman, President & CEO | 2026-02-23 | 68,252 | D | 361,921 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin | 2026-02-23 | 25,742 | A | 34,710 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Shelley M Capito | Senator | 2025-08-04 | Sale (Full) | 2025-07-31 | Spouse | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2021-07-23 | Sale (Full) | 2021-03-29 | Joint | $1,001 - $15,000 |
| Kelly Loeffler | Senator | 2020-05-01 | Sale (Full) | 2020-04-14 | Self | $100,001 - $250,000 |
| Kelly Loeffler | Senator | 2020-05-01 | Sale (Full) | 2020-04-14 | Spouse | $100,001 - $250,000 |
| Kelly Loeffler | Senator | 2020-05-01 | Purchase | 2020-04-07 | Spouse | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Lisa McClain | 2025-10-22 | MI09 | Sale | 2025-09-11 | Spouse | $1,001 - $15,000 |
| Rick Larsen | 2025-10-16 | WA02 | Sale | 2025-10-06 | — | $1,001 - $15,000 |
| Tim Moore | 2025-10-10 | NC14 | Sale | 2025-09-10 | — | $1,001 - $15,000 |
| Julie Johnson | 2025-10-07 | TX32 | Sale | 2025-09-25 | Joint | $1,001 - $15,000 |
| Lisa McClain | 2025-09-12 | MI09 | Purchase | 2025-08-13 | Spouse | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| TOBAM | 2025-12-31 | 1,610,000 | 20,374 | 79.0223 |
| Cross Staff Investments Inc | 2025-12-31 | 379,296 | 4,800 | 79.02 |
| GROUPAMA ASSET MANAGMENT | 2025-12-31 | 2,058,392 | 26,049 | 79.02 |
| Anchor Investment Management, LLC | 2025-12-31 | 929,907 | 11,768 | 79.02 |
| TD Capital Management LLC | 2025-12-31 | 25,741 | 326 | 78.9601 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| SEI INSTITUTIONAL MANAGED TRUST | 2025-12-31 | Class Y | SLRYX | 63,063 | 4,983,238.26 | 0.3242 |
| SEI INSTITUTIONAL MANAGED TRUST | 2025-12-31 | CLASS F | SELCX | 63,063 | 4,983,238.26 | 0.3242 |
| SEI INSTITUTIONAL MANAGED TRUST | 2025-12-31 | CLASS I | SPGIX | 63,063 | 4,983,238.26 | 0.3242 |
| SEI Exchange Traded Funds | 2025-12-31 | SEI Enhanced Low Volatility U.S. Large Cap ETF | SELV | 51,494 | 4,069,055.88 | 1.9756 |
| SEI Exchange Traded Funds | 2025-12-31 | SEI Enhanced U.S. Large Cap Quality Factor ETF | SEIQ | 136,920 | 10,819,418.4 | 2.0981 |